3-Weekly Daratumumab-Imid-dexamethasone is Highly Efficacious and Cost-Effective in Relapsed/refractory Multiple Myeloma.
Journal of Clinical Oncology（2019）
Key words
3-weekly daratumumab,cost-effectiveness,dara-IMiD-dex
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined